glp 1 approved for osa Yes, GLP-1s Treat (Some) OSA, But They Also Expose Limits of Obesity-Focused Strategies Zepbound: Weight Loss Drugs Can

A larger clinical trial randomly assigned more than 500 patients with type 2 diabetes and symptomatic peripheral neuropathy to one of the following treatments: (i) 600 mg/day of intravenous lipoic acid for three weeks followed by 1,800 mg/day of oral lipoic acid for six months, (ii) 600 mg/day of intravenous lipoic acid for three weeks followed by oral placebo for six months, or (iii) intravenous placebo for three weeks followed by oral placebo for six months (76)

CJC-1295 (100-300mcg before bed) for extended GH release

& Lipsman, N

Br J Cancer

Carnitine, derived from an amino acid , is the generic term for several compounds

Regarding weight loss, the FDA has approved these drugs for people whose body mass index (BMI) is greater than 30 kg/m2, or they have a BMI that is greater than 27 and have a weight-related health problem, such as high blood pressure, sleep apnea, or pre-diabetes